

















Hartmann Young was built on the belief that genuine market understanding cannot be manufactured. It comes from proximity to the industry, relationships with the people who lead it and a sustained presence within the sectors we serve.
Our advisory board exists for that reason. Not as a formality, but as a deliberate connection to senior leaders who have operated at the highest levels of life sciences.
Our advisory board brings together leaders who have built, scaled, led and recruited within life sciences organisations.Their experience helps challenge our thinking, refine our approach and ensure Hartmann Young remains closely aligned to the realities facing the markets we serve.
They contribute:
Commercial and operational insight
They contribute:
Leadership and hiring perspective
They contribute:
Industry introductions and network access
They contribute:
Market expertise across specialist sectors
They contribute:
Strategic guidance that supports our continued development
The advisory board represents direct leadership experience across biotechnology, diagnostics, medtech, pharmaceutical development, life science tools and life sciences investment. Members have led organisations through clinical development, commercial scale, international expansion and transaction.
That range of experience across sectors, geographies and growth stages gives Hartmann Young a perspective on leadership that is specific, current and hard to replicate.

Mary Gunn is an accomplished Chair, Non-Executive Director, and CEO with over 20 years of leadership experience across life sciences, financial services, and education. She brings deep expertise in governance, investments, and strategic growth, with a strong track record in fundraising, M&A, licensing, and global expansion. Mary has led organisations from start-ups to Fortune 100 companies, overseeing operations in 75 countries and portfolios exceeding $2.4B. Her multidisciplinary background in psychology, medical law, business, and global politics underpins her proven ability to drive innovation and high-performing leadership.

Maddy serves as Global Head of Human Resources at Phagenesis, a mission-led MedTech company revolutionising care for patients with neurogenic dysphagia. Leading the people strategy across the UK, USA, Germany, and Austria, Maddy previously held the position of Sr. Manager, Global HR Business Partner at QIAGEN, a global leading life science and MDx organisation. Maddy brings not only deep HR expertise, but also contagious energy and a fresh, forward-thinking perspective.

Sean brings over two decades of experience building and scaling innovative healthcare technology companies, with deep expertise in Genomics, Telemedicine, and AI-driven SaaS platforms. His career includes raising more than $186 million in growth capital, scaling a healthcare SaaS business by 400% in under three years, and founding Three Leaf Ventures, where he built a portfolio of 13 companies and achieved four successful exits through IPO and M&A.

Heather is the Founder of strategic consultancy Nutrachievement Inc and brings over 30 years of experience in the global nutraceutical and food sectors. She has held senior leadership positions with globally recognised brands including SupplySide, Vitafoods, and Food ingredients Europe, and is a respected voice in the industry for her work in content strategy, communications, business development, and international collaboration.

Jeremy brings with him more than 15 years of leadership in diagnostics and over 25 years in the broader life sciences industry. His deep market insight and industry expertise align perfectly with our specialisms, and we are excited to leverage his experience as we continue to grow.

With extensive expertise in diagnostics and life sciences, Dr. Bhuwnesh Agrawal's addition marks a significant milestone as we continue to expand our impact in the life sciences talent space. His track record of working alongside some of the most recognised names in diagnostics will be instrumental in shaping our strategic direction.